Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Hengye Biotech is a specialized biotechnology firm based in Jinan, China, focusing on the research, development, and large-scale production of core raw materials for the In Vitro Diagnostics (IVD) sector. The company provides a comprehensive portfolio of biological reagents, including high-purity recombinant enzymes, antigens, and monoclonal antibodies tailored for immunodiagnostics and molecular testing. Their products support a variety of clinical applications such as infectious disease screening, tumor marker detection, and cardiovascular health monitoring. By leveraging advanced protein expression and purification platforms, Shandong Hengye Biotech serves as a critical supplier to diagnostic kit manufacturers and research institutions globally. The company maintains rigorous quality control standards to ensure the performance and stability of its diagnostic components.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Hengye Biotech.